Psilera Secures $8.8 Million in Latest Seed Funding Round

Psilera secured $8.8 million in its latest Seed, adding another data point to the Healthcare funding market.

Psilera Raises $8.8 million in Funding

Psilera: $8.8 Million Seed Round Closed To Advance Neuroplastogen PSIL-006 Into Clinical Trials is a healthcare company that announced a seed round.

Investors Behind the Funding

The round was backed by undisclosed investors. Funding Intelligence tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Psilera operates in Healthcare. Psilera: $8.8 Million Seed Round Closed To Advance Neuroplastogen PSIL-006 Into Clinical Trials joining the Seed market points to continued investor appetite in healthcare. This looks like capital aimed at scaling product, hiring, and go-to-market rather than a late-cycle liquidity event.

Strategic Use of Funds

Scale product development, team growth, and go-to-market execution.

Looking Ahead

Psilera: $8.8 Million Seed Round Closed To Advance Neuroplastogen PSIL-006 Into Clinical Trials - Pulse 2.0

Source reference: original announcement/article.